J. Neuberger et al., Pretransplant prediction of prognosis after liver transplantation in primary sclerosing cholangitis using a Cox regression model, HEPATOLOGY, 29(5), 1999, pp. 1375-1379
Liver transplantation remains the only treatment for patients with end-stag
e primary sclerosing cholangitis (PSC); however, selection criteria for the
procedure and its timing remains uncertain. The aim of this study was to i
dentify pretransplant variables associated with survival after transplantat
ion and to devise a Cox regression model for prediction of post-transplant
survival, We studied 118 patients transplanted for PSC at the Queen Elizabe
th Hospital, Birmingham, UK, being followed for up to 91/4 years after the
procedure. The association between pretransplant data and the post-transpla
nt survival up to 1 year was studied using the logrank test (univariate ana
lyses) and Cox multiple regression analysis. Univariate analyses showed the
following variables to be associated with a decreased post-transplant surv
ival: high serum creatinine, high serum bilirubin, biliary tree malignancy,
previous upper abdominal surgery, hepatic encephalopathy, ascites, and Cro
hn's disease, whereas ulcerative colitis was associated with increased post
-transplant survival (all P less than or equal to .05). The final multiple
Cos regression model included the following significant variables: inflamma
tory bowel disease, ascites, previous upper abdominal surgery, serum creati
nine, and biliary tree malignancy (all P < .03). Biliary tree malignancy co
uld be omitted from the Cos model with only slight loss of information. The
results were validated using the data of 30 independent PSC patients from
another center. These results can improve selection of patients with PSC fo
r liver transplantation. The developed prognostic model for transplantation
can be used in parallel with previously published prognostic models for no
ntransplantation. The obtained prognostic estimates will provide additional
information that is useful for optimal timing of liver transplantation in
the individual patient.